Matches in Wikidata for { <http://www.wikidata.org/entity/Q91134053> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91134053 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91134053 description "scientific article published on 06 November 2019" @default.
- Q91134053 description "wetenschappelijk artikel" @default.
- Q91134053 description "наукова стаття, опублікована 6 листопада 2019" @default.
- Q91134053 name "(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ" @default.
- Q91134053 name "(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ" @default.
- Q91134053 type Item @default.
- Q91134053 label "(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ" @default.
- Q91134053 label "(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ" @default.
- Q91134053 prefLabel "(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ" @default.
- Q91134053 prefLabel "(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ" @default.
- Q91134053 P1433 Q91134053-D00427E6-A81D-41B6-B6C3-FACB8D00E668 @default.
- Q91134053 P1476 Q91134053-41B6EA39-98E6-45E4-8E95-64D4E6ABF1EA @default.
- Q91134053 P2093 Q91134053-694B646B-02AB-45CA-85E8-1F6E537082DB @default.
- Q91134053 P2093 Q91134053-6B3F4927-F92B-4505-8223-82D4295DB786 @default.
- Q91134053 P2093 Q91134053-9A71AAD0-71ED-4529-86D3-636C263F04A1 @default.
- Q91134053 P2093 Q91134053-DA98B632-C1D0-453A-BCBE-26A4BA8DDB23 @default.
- Q91134053 P2093 Q91134053-E6EABAC2-0B7A-46F0-B99D-CF541674CA9D @default.
- Q91134053 P304 Q91134053-58062FE8-7DE6-448F-8D2F-ACBC973C1911 @default.
- Q91134053 P31 Q91134053-D2BC067B-045F-4A38-AF1A-37CFFB3BF9F4 @default.
- Q91134053 P356 Q91134053-9A309A31-C222-49E5-8C63-23A38352015E @default.
- Q91134053 P433 Q91134053-5EE9E2B7-1227-470E-B830-1FAE9291C1F5 @default.
- Q91134053 P478 Q91134053-81543123-2E35-4E3D-B6A5-4BF23E48022D @default.
- Q91134053 P577 Q91134053-E0DA7DE0-EE31-4321-A2A7-9F124780B7B4 @default.
- Q91134053 P698 Q91134053-E0428AB3-ADA5-49C0-AED7-D145B91BA415 @default.
- Q91134053 P356 08923973.2019.1678634 @default.
- Q91134053 P698 31691624 @default.
- Q91134053 P1433 Q4200316 @default.
- Q91134053 P1476 "(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ" @default.
- Q91134053 P2093 "ChunMei Dai" @default.
- Q91134053 P2093 "JunBao Liu" @default.
- Q91134053 P2093 "Lu Cao" @default.
- Q91134053 P2093 "Rui Qin" @default.
- Q91134053 P2093 "YaHua Guo" @default.
- Q91134053 P304 "599-606" @default.
- Q91134053 P31 Q13442814 @default.
- Q91134053 P356 "10.1080/08923973.2019.1678634" @default.
- Q91134053 P433 "6" @default.
- Q91134053 P478 "41" @default.
- Q91134053 P577 "2019-11-06T00:00:00Z" @default.
- Q91134053 P698 "31691624" @default.